| 51 |
20735423 | Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro. | 2010 Sep |
1 |
| 52 |
20837591 | Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions. | 2010 Oct |
1 |
| 53 |
19261952 | Evaluation of potential interaction between vinorelbine and clarithromycin. | 2009 Mar |
1 |
| 54 |
19414584 | Modeling the autoinhibition of clarithromycin metabolism during repeated oral administration. | 2009 Jul |
3 |
| 55 |
19457725 | Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography-tandem mass spectrometry. | 2009 Jun 15 |
1 |
| 56 |
19701237 | Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism. | 2009 Sep |
1 |
| 57 |
17635500 | Interaction between midazolam and clarithromycin in the elderly. | 2008 Jan |
2 |
| 58 |
18558792 | Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors. | 2008 |
1 |
| 59 |
19122337 | Effect of clarithromycin on the pharmacokinetics of pranlukast in healthy volunteers. | 2008 |
1 |
| 60 |
17381388 | Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients. | 2007 Apr |
1 |
| 61 |
17484517 | Drug-drug interactions in the metabolism of imidafenacin: role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes. | 2007 Feb |
1 |
| 62 |
17695796 | [Measurement of rifampicin and clarithromycin in serum by high-performance liquid chromatography with electrochemical detection]. | 2007 Jul |
3 |
| 63 |
18033049 | [Carbamazepine and clarithromycin: a clinically relevant drug interaction]. | 2007 Nov |
1 |
| 64 |
16372380 | The effect of ciprofloxacin and clarithromycin on sildenafil oral bioavailability in human volunteers. | 2006 Mar |
3 |
| 65 |
16410677 | Effect of clarithromycin on the pharmacokinetics of cabergoline in healthy controls and in patients with Parkinson's disease. | 2006 Jan |
1 |
| 66 |
16416302 | Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate. | 2006 Mar |
1 |
| 67 |
15735612 | Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression. | 2005 Mar |
3 |
| 68 |
15752376 | Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes. | 2005 Mar |
2 |
| 69 |
15856433 | Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes. | 2005 Jun |
2 |
| 70 |
14715050 | Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs. | 2004 |
1 |
| 71 |
15058617 | Drug interactions in dentistry: the importance of knowing your CYPs. | 2004 Mar |
2 |
| 72 |
12949438 | Inhibition of cytochrome P450 3A: relevant drug interactions in gastroenterology. | 2003 |
1 |
| 73 |
14570755 | Evidence for the validity of cortisol 6 beta-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans. | 2003 Nov |
2 |
| 74 |
15618724 | CYP isoforms involved in the metabolism of clarithromycin in vitro: comparison between the identification from disappearance rate and that from formation rate of metabolites. | 2003 |
4 |
| 75 |
11197581 | Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin. | 2001 Jan |
1 |
| 76 |
11322176 | Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine. | 2001 Apr |
1 |
| 77 |
11408986 | Effect of levofloxacin on theophylline clearance during theophylline and clarithromycin combination therapy. | 2001 Jun |
1 |
| 78 |
11836874 | [Safety profile of statins]. | 2001 Nov |
1 |
| 79 |
10668858 | Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. | 2000 Jan |
1 |
| 80 |
10722500 | Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers. | 2000 Apr |
1 |
| 81 |
10923859 | Identification of enzymes responsible for rifalazil metabolism in human liver microsomes. | 2000 Jun |
1 |
| 82 |
10926350 | Drug interactions with cisapride: clinical implications. | 2000 Jul |
1 |
| 83 |
10950845 | An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation. | 2000 Sep |
5 |
| 84 |
11012550 | Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin. | 2000 Oct |
1 |
| 85 |
9951426 | Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6). | 1999 Jan |
3 |
| 86 |
9972380 | Torsade de pointes induced by cisapride/clarithromycin interaction. | 1999 Jan |
1 |
| 87 |
10383920 | An in vitro study on the metabolism and possible drug interactions of rokitamycin, a macrolide antibiotic, using human liver microsomes. | 1999 Jul |
1 |
| 88 |
10511062 | Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans. | 1999 Sep |
1 |
| 89 |
10589373 | Clinical pharmacokinetics of clarithromycin. | 1999 Nov |
3 |
| 90 |
10600094 | Potential interaction between itraconazole and clarithromycin. | 1999 Dec |
1 |
| 91 |
9640482 | Syncopal episodes associated with cisapride and concurrent drugs. | 1998 Jun |
2 |
| 92 |
9728893 | The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. | 1998 Aug |
2 |
| 93 |
9131953 | The mechanism of cyclosporine toxicity induced by clarithromycin. | 1997 Feb |
3 |